- Home
- Search Results
- Page 1 of 1
Search for: All records
-
Total Resources2
- Resource Type
-
20
- Availability
-
20
- Author / Contributor
- Filter by Author / Creator
-
-
Powell, Abigail E. (2)
-
Blake, Timothy R. (1)
-
Czerwinski, Debra K. (1)
-
Goodrich, James A. (1)
-
Haabeth, Ole A. (1)
-
Kugel, Jennifer F. (1)
-
Levy, Ronald (1)
-
Lohmeyer, Julian J. (1)
-
Ly, Elina (1)
-
McCarthy, Blaine (1)
-
Sagiv-Barfi, Idit (1)
-
Sallets, Adrienne (1)
-
Waymouth, Robert M. (1)
-
Wender, Paul A. (1)
-
#Tyler Phillips, Kenneth E. (0)
-
& *Soto, E. (0)
-
& Ahmed, Khadija. (0)
-
& Akcil-Okan, O. (0)
-
& Akuom, D. (0)
-
& Andrews-Larson, C. (0)
-
- Filter by Editor
-
-
& Ahn, J. (0)
-
& Bateiha, S. (0)
-
& Chen, B. (0)
-
& Chen, Bodong (0)
-
& Kali, Y. (0)
-
& Ruiz-Arias, P.M. (0)
-
& Spitzer, S. (0)
-
& Spitzer, S.M. (0)
-
:Chaosong Huang, Gang Lu (0)
-
A. Beygelzimer (0)
-
A. Ghate, K. Krishnaiyer (0)
-
A. I. Sacristán, J. C. (0)
-
A. Weinberg, D. Moore-Russo (0)
-
A. Weinberger (0)
-
A.I. Sacristán, J.C. Cortés-Zavala (0)
-
A.I., Dimitrova (0)
-
ACS (0)
-
AIAA (0)
-
AIAA Propulsion and Energy 2021 (0)
-
AIAA SciTech (0)
-
-
Have feedback or suggestions for a way to improve these results?
!
Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher.
Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?
Some links on this page may take you to non-federal websites. Their policies may differ from this site.
-
The SARS-CoV-2 pandemic has necessitated the rapid development of prophylactic vaccines. Two mRNA vaccines have been approved for emergency use by the FDA and have demonstrated extraordinary effectiveness. The success of these mRNA vaccines establishes the speed of development and therapeutic potential of mRNA. These authorized vaccines encode full-length versions of the SARS-CoV-2 spike protein. They are formulated with lipid nanoparticle (LNP) delivery vehicles that have inherent immunostimulatory properties. Different vaccination strategies and alternative mRNA delivery vehicles would be desirable to ensure flexibility of future generations of SARS-CoV-2 vaccines and the development of mRNA vaccines in general. Here, we reportmore »
-
Ly, Elina ; Powell, Abigail E. ; Goodrich, James A. ; Kugel, Jennifer F. ( , Journal of Molecular Biology)